Vitrea 4.0 and ViTALConnect offer advanced visualization and analysis capabilities via workstation clients, remote clients and Web-based clients. These releases include enhancements to the company’s cardiovascular, neurovascular and gastrointestinal applications as well as improved Web-based cardiovascular analysis and distribution capabilities.
A third round of software enhancements made to the iLab System 1.3, an ultrasound imaging system designed to strengthen ...
This may be the Red Bull of interventional cardiology sessions, since The Society of Cardiovascular Angiography and Interventions (SCAI) and ACC’s Innovation in Intervention: i2 Summit joined forces to form the “SCAI-ACCi2” meeting.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
FUJIFILM’s Synapse 3.2.1 software, an extension of version 3.2, with a new Graphic User Interface (GUI), will be featured at ACC 2008. GUI changes include increase use of color to help identify changes in information on the display, new icons and a contrast scheme designed for radiology viewing conditions.
March 12, 2008 - Siemens will showcase its latest ultrasound technologies, focusing on its ACUSON S2000, ACUSON X300 and ...
The success or failure of coronary intervention starts with a winning combination of guiding catheter and coronary guidewire, which gives the operator the optimal support and stability to accomplish the interventional goals. The Terumo Runthrough NS coronary guidewire has some unique properties, which allows access to a broad range of complex anatomies.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
Zollï's E Series defibrillators with a 12-lead reportedly offer a variety of transmission solutions and can be tailored ...
March 11, 2008 – Medtronic Inc. will feature its newly FDA-cleared Endeavor Zotarolimus-Eluting Coronary Stent System ...
Choosing the right device to regulate or jump-start the heart can be a challenge. Not only does a patient’s symptoms often dictate whether a pacemaker or defibrillator is a more appropriate treatment, but new advances in technology are making the choice between available devices more difficult.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
Fujifilm will highlight the newest CVIIS release Version 4.0 from ProSolv Cardiovascular. This release, which integrates ...
March 10, 2008 – The Medical Imaging & Technology Alliance (MITA), a division of NEMA, today praised the 88 Members of ...
March 11, 2008 - St. Jude Medical Inc. received regulatory approval from the Ministry of Health, Labor and Welfare (MHLW ...
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
Sorin Group's ELA Medical markets ISOLINE, a defibrillation lead designed with redundant insulation and abrasion resistant materials for longevity and safety.
March 11, 2008 - Abbott announced today that it has received CE Mark (Conformite Europeene) approval for a 2.25 mm ...
NovaRad’s NovaPACS Cardio Viewer offers sign-on access to images or over a Web site. Features in this module include ...